ADARx Pharmaceuticals
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5871 Oberlin Dr Ste 200, San Diego, Cali...Phone Number
(877) 232-7974Website
www.adarx.comRevenue
$7.6 MillionIndustry
About ADARx Pharmaceuticals
ADARx Pharmaceuticals Org Chart
Is ADARx Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ADARx Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ADARx Pharmaceuticals has new funding data
Earning: See what the market has to say on ADARx Pharmaceuticals recently announced quarterly report
Check out if ADARx Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if ADARx Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ADARx Pharmaceuticals launches new products
Click to see if ADARx Pharmaceuticals had a recent Job posting/layoffs
ADARx Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at ADARx Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to ADARx Pharmaceuticals
Compare insights from companies similar to ADARx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ADARx Pharmaceuticals
Company Profile Activity
Activity Insights
ADARx Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ADARx Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ADARx Pharmaceuticals.
ADARx Pharmaceuticals financials insights
Gather financial insights about ADARx Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Unspecified
$5M
Unspecified
$6M
Series B
$75M
Series C
$200M
ADARx Pharmaceuticals Tech Stack
A closer look at the technologies used by ADARx Pharmaceuticals
Most Recent Scoops
ADARx Pharmaceuticals News & Media
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as CFO and CBOADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
– Onvuzosiran achieved significant and durable reductions of plasma kallikrein levels with a favorable safety profile in Phase 1/2 –ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual MeetingADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
– Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and healthcare industry –
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ADARx Pharmaceuticals
ADARx Pharmaceuticals is located in San Diego, California, United States and was established in 2019. They are a biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with n... Read More